
Boom or Bubble? The soaring stakes in the AI gold rush
There has never been a surge in investment in the artificial intelligence industry like what's happening now. Billions of dollars are pouring into firms promising to change the future of technology. This surge came after OpenAI released ChatGPT, an AI chatbot based on the GPT language model.
OpenAI is at the top of the AI valuation table. According to a report by CB Insights, it is now the most valuable AI startup in the world, worth USD 300 billion. It has grown quickly thanks to partnerships and a wave of funding, with the most recent round bringing in $40 billion in March 2025, led by SoftBank Group.
Apart from OpenAI, Databricks and Anthropic are two other US-based firms betting on AI and worth more than USD 60 billion. Elon Musk's AI company, xAI, has also made it to the top, making it one of the four AI businesses among the world's ten most valuable private tech companies.
The dominance of US-based companies in this sector is striking. Seven of the eight highest-valued AI startups are headquartered in the United States. The only exception is Celonis, a German firm specialising in process optimisation through AI and other technologies. Despite its European roots, Celonis has a strong presence in the US market and is currently valued at $13 billion.
One of the newer entrants generating buzz is Safe Superintelligence, a US startup founded just last year by a team of former OpenAI, Apple, and academic researchers. Despite raising only USD 3 billion, the company is already valued at USD 30 billion. Its mission is to build a superintelligent AI system that prioritises safety above all else.
Another startup making headlines is Thinking Machines Lab, founded by former OpenAI Chief Technology Officer Mira Murati. It has just closed a massive USD 2 billion seed round, pushing its valuation to USD 12 billion.
However, not all that glitters in AI space is gold. As companies scale up AI projects, a recent Gartner report warns that over 40 per cent of projects involving "agentic" AI (systems designed to make decisions and act autonomously) will be cancelled by the end of 2027. The research firm cites high development costs, unclear return on investment, and technological immaturity as key reasons. It also raised a growing trend of "agent washing," where companies label traditional tools as intelligent agents without delivering on the promises. However, Gartner reports that agentic AI adoption is growing steadily, forecasting that by 2028, it will drive 15 per cent of daily business decisions and power a third of enterprise applications.
Despite the rising valuations and adoption of AI in everyday life, public perception remains cautious, sharply contrasting with expert views. A recent Pew Research Center survey found that while 47 per cent of AI researchers feel more excited than concerned about AI's growing role in daily life, 51 per cent of US adults feel the opposite. Both groups are worried about misinformation, deepfakes, and privacy issues, but they disagree on things like losing jobs and being socially isolated.
There has never been a surge in investment in the artificial intelligence industry like what's happening now. Billions of dollars are pouring into firms promising to change the future of technology. This surge came after OpenAI released ChatGPT, an AI chatbot based on the GPT language model.
OpenAI is at the top of the AI valuation table. According to a report by CB Insights, it is now the most valuable AI startup in the world, worth USD 300 billion. It has grown quickly thanks to partnerships and a wave of funding, with the most recent round bringing in $40 billion in March 2025, led by SoftBank Group.
Apart from OpenAI, Databricks and Anthropic are two other US-based firms betting on AI and worth more than USD 60 billion. Elon Musk's AI company, xAI, has also made it to the top, making it one of the four AI businesses among the world's ten most valuable private tech companies.
The dominance of US-based companies in this sector is striking. Seven of the eight highest-valued AI startups are headquartered in the United States. The only exception is Celonis, a German firm specialising in process optimisation through AI and other technologies. Despite its European roots, Celonis has a strong presence in the US market and is currently valued at $13 billion.
One of the newer entrants generating buzz is Safe Superintelligence, a US startup founded just last year by a team of former OpenAI, Apple, and academic researchers. Despite raising only USD 3 billion, the company is already valued at USD 30 billion. Its mission is to build a superintelligent AI system that prioritises safety above all else.
Another startup making headlines is Thinking Machines Lab, founded by former OpenAI Chief Technology Officer Mira Murati. It has just closed a massive USD 2 billion seed round, pushing its valuation to USD 12 billion.
However, not all that glitters in AI space is gold. As companies scale up AI projects, a recent Gartner report warns that over 40 per cent of projects involving "agentic" AI (systems designed to make decisions and act autonomously) will be cancelled by the end of 2027. The research firm cites high development costs, unclear return on investment, and technological immaturity as key reasons. It also raised a growing trend of "agent washing," where companies label traditional tools as intelligent agents without delivering on the promises. However, Gartner reports that agentic AI adoption is growing steadily, forecasting that by 2028, it will drive 15 per cent of daily business decisions and power a third of enterprise applications.
Despite the rising valuations and adoption of AI in everyday life, public perception remains cautious, sharply contrasting with expert views. A recent Pew Research Center survey found that while 47 per cent of AI researchers feel more excited than concerned about AI's growing role in daily life, 51 per cent of US adults feel the opposite. Both groups are worried about misinformation, deepfakes, and privacy issues, but they disagree on things like losing jobs and being socially isolated. Join our WhatsApp Channel

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
18 minutes ago
- Time of India
Ashish Kacholia invested in this SME IPO that has 42% GMP. Check all details
Patel Chem Specialities is set to launch its Rs 58.80 crore IPO today, with the price fixed at Rs 82–84 per share. Ahmedabad-based Patel Chem Specialities launched its Rs 58.80 crore IPO today, priced at Rs 82–84 per share. The IPO, entirely a fresh issue, closes on July 29 and plans to list on BSE SME on August 1. Ashish Kacholia, along with other investors, participated in the anchor book, raising Rs 16.69 crore. Tired of too many ads? Remove Ads Price band and GMP Tired of too many ads? Remove Ads Company overview Ahmedabad-based excipient maker Patel Chem Specialities will launch its Rs 58.80 crore IPO today at a price band of Rs 82–84 per share. The offer is entirely a fresh issue of 70 lakh equity shares and will close for subscription on July 29. The company will list on the BSE SME platform, with a tentative listing date of August IPO has drawn early attention after ace investor Ashish Kacholia , via Bengal Finance and Investment, was allotted 5.97 lakh shares as part of the anchor book at Rs 84 per share -- accounting for nearly one-third of the anchor notable investors include Meru Investment Fund, Zeal Global Opportunities Fund, and Ventura Fund I. In total, Rs 16.69 crore was raised from anchor issue is priced at Rs 82–84 per share with a lot size of 1,600 shares. The grey market premium (GMP) is hovering at around 42% over the issue price, indicating strong interest ahead of Chem is a manufacturer of pharmaceutical excipients and specialty chemicals like sodium carboxymethyl cellulose and pregelatinized operates from two plants in Gujarat and exports to over five continents. For FY25, it posted a 28% revenue growth to Rs 105.5 crore, while PAT jumped 38% to Rs 10.57 proceeds from the IPO will be used for funding capital expenditure requirement of the company and other general corporate purposes.


Economic Times
18 minutes ago
- Economic Times
Ashish Kacholia invested in this SME IPO that has 42% GMP. Check all details
Ahmedabad-based excipient maker Patel Chem Specialities will launch its Rs 58.80 crore IPO today at a price band of Rs 82–84 per share. The offer is entirely a fresh issue of 70 lakh equity shares and will close for subscription on July 29. The company will list on the BSE SME platform, with a tentative listing date of August 1. ADVERTISEMENT The IPO has drawn early attention after ace investor Ashish Kacholia, via Bengal Finance and Investment, was allotted 5.97 lakh shares as part of the anchor book at Rs 84 per share -- accounting for nearly one-third of the anchor portion. Other notable investors include Meru Investment Fund, Zeal Global Opportunities Fund, and Ventura Fund I. In total, Rs 16.69 crore was raised from anchor investors. The issue is priced at Rs 82–84 per share with a lot size of 1,600 shares. The grey market premium (GMP) is hovering at around 42% over the issue price, indicating strong interest ahead of Chem is a manufacturer of pharmaceutical excipients and specialty chemicals like sodium carboxymethyl cellulose and pregelatinized starch. ADVERTISEMENT It operates from two plants in Gujarat and exports to over five continents. For FY25, it posted a 28% revenue growth to Rs 105.5 crore, while PAT jumped 38% to Rs 10.57 proceeds from the IPO will be used for funding capital expenditure requirement of the company and other general corporate purposes. ADVERTISEMENT (You can now subscribe to our ETMarkets WhatsApp channel)


Economic Times
18 minutes ago
- Economic Times
Shanti Gold International IPO opens for subscription with healthy GMP. Should you subscribe?
Live Events Should you subscribe? (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel The Rs 360-crore IPO of Shanti Gold International opened for subscription on Friday in the price band of Rs 189–199 per share. The offer comprises a pure fresh issue of 1.81 crore equity shares and will close on July 29. The company is expected to list on the BSE and NSE on August grey market premium (GMP) for the IPO is currently hovering around Rs 40, indicating a 20% listing gain Gold International, a Mumbai-based manufacturer of 22kt CZ casting gold jewellery, operates primarily on a B2B model and caters to large retail chains including Joyalukkas, Lalithaa Jewellery Mart and designs are sold across southern India, which currently contributes more than 70% of revenue. The firm plans to expand into North India with a new 1,200 kg manufacturing unit in Jaipur — a strategic move to enter the plain jewellery the company has shown robust growth. Revenue rose from Rs 679 crore in FY23 to Rs 1,106 crore in FY25, while net profit surged from Rs 19.8 crore to Rs 55.8 crore during the same period, reflecting a strong CAGR of 68%.EBITDA margins have expanded steadily to 8.83%, and the return on equity (RoE) stood at a healthy 44.85% in FY25. The IPO values the company at a post-issue P/E of 19x, which is at a discount to the industry average of 23x. However, the price-to-book valuation at 7x appears slightly stretched compared to listed have recommended subscribing to the issue, citing strong financials, margin expansion, and a clear strategy to diversify its product mix and regional footprint."The company's robust relationships with marquee jewellers, expanding design capabilities (over 400 designs/month), and controlled in-house manufacturing give it scale and brand trust in the B2B jewellery segment," said Canara Bank risks such as customer and regional concentration exist, the growth momentum and business fundamentals remain attractive.